Comparative Analysis of Intralesional Immunotherapy and Conventional Treatments for Non-Genital Warts: A Systematic Review and Network Meta-Analysis
Keywords:
intralesional, cryotherapy, HPV, immunotherapy, Meta-analysis, viral wartAbstract
Introduction: Warts, benign skin growths caused by various human papillomavirus strains, are categorized as genital and non-genital. Non-genital warts often lack noticeable symptoms but can lead to psychological distress due to factors like embarrassment. Traditional treatments, including physical and chemical methods, show limitations, prompting the exploration of novel approaches like intralesional immunotherapy. The clinical challenge lies in selecting the most effective modality.
Objective: In our study, we used the network meta-analysis (NMA) as a statistical tool to explore the most effective intralesional immunotherapy interventions.
Methods: Comprehensive searches of Web of Science, PubMed, Cochrane, and Scopus databases were conducted until December 2023. Eligible studies were analyzed for outcomes presented as risk ratios (RRs) with 95% confidence intervals (CI). Treatments were ranked using the P-score in an NMA performed with R software.
Results: We included 68 RCTs in our study. For complete response, needling showed a significant difference compared to Candida albicans antigen (RR= 0.13, 95% CI [0.02; 0.99]) and Mw (RR= 0.12, 95% CI [0.02; 0.94]). In overall response, both bleomycin and furosemide with digoxin were significant compared to autoimplantation (RR= 0.46, 95% CI [0.24; 0.88]) and (RR= 0.40, 95% CI [0.18; 0.91]) respectively. Similarly, both were significant compared to cryotherapy (RR= 0.45, 95% CI [0.27; 0.76]) and (RR= 0.40, 95% CI [0.19; 0.82]) respectively.
Conclusion: This NMA indicates needling, furosemide with digoxin, and PBP antigen stimulants as effective for non-genital warts, surpassing traditional treatments in complete and overall response. Direct comparisons in future research are warranted to confirm their superiority.
References
Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30 Suppl 5:F12-F23. doi:10.1016/j.vaccine.2012.07.055
Rowson KE, Mahy BW. Human papova (wart) virus. Bacteriol Rev. 1967;31(2):110-131. doi:10.1128/br.31.2.110-131.1967
Kuriyama Y, Kosaka M, Kaneko A, et al. Skin surface material for detecting human papillomavirus infection of skin warts. J Dermatol. 2023;50(11):1450-1458. doi:10.1111/1346-8138.16920
Jabłońska S, Majewski S, Obalek S, Orth G. Cutaneous warts. Clin Dermatol. 1997;15(3):309-319. doi:10.1016/s0738-081x(96)00170-8
Tosti A, Piraccini BM. Warts of the nail unit: surgical and nonsurgical approaches. Dermatol Surg. 2001;27(3):235-239.
MONTGOMERY AH, MONTGOMERY RM. Mosaic type of plantar wart, its characteristics and treatment. Arch Derm Syphilol. 1948;57(3):397-399. doi:10.1001/archderm.1948.01520150119017
Monk BJ, Tewari KS. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol. 2007;107(2 Suppl 1):S6-S13. doi:10.1016/j.ygyno.2007.07.076
Plasencia JM. Cutaneous warts: diagnosis and treatment. Prim Care. 2000;27(2):423-434. doi:10.1016/s0095-4543(05)70204-9
Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis. 2012;205(10):1544-1553. doi:10.1093/infdis/jis228
Dediol I, Buljan M, Vurnek-A Ivkoviä M, Bulat V, A Itum M, A Ubriloviä A. Psychological burden of anogenital warts. J Eur Acad Dermatol Venereol. 2009;23(9):1035-1038. doi:10.1111/j.1468-3083.2009.03242.x
Ciconte A, Campbell J, Tabrizi S, Garland S, Marks R. Warts are not merely blemishes on the skin: A study on the morbidity associated with having viral cutaneous warts. Australas J Dermatol. 2003;44(3):169-173. doi:10.1046/j.1440-0960.2003.00672.x
Leow MQH, Oon HHB. The impact of viral warts on the quality of life of patients. Dermatol Nurs. 2016;15(4):44-48.
Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician. 2005;72(4):647-652.
Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17(6):441-448. doi:10.1111/j.1396-0296.2004.04047.x
Miller DJ, Strauch RJ. Management of Cutaneous Warts of the Hand. J Hand Surg Am. 2015;40(11):2274-2276. doi:10.1016/j.jhsa.2015.07.020
Simonart T, de Maertelaer V. Systemic treatments for cutaneous warts: a systematic review. J Dermatolog Treat. 2012;23(1):72-77. doi:10.3109/09546634.2010.500324
Aldahan AS, Mlacker S, Shah VV, et al. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature. Dermatol Ther. 2016;29(3):197-207. doi:10.1111/dth.12352
Nofal A, Salah E, Nofal E, Yosef A. Intralesional antigen immunotherapy for the treatment of warts: current concepts and future prospects. Am J Clin Dermatol. 2013;14(4):253-260. doi:10.1007/s40257-013-0018-8
Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008;17(3):279-301. doi:10.1177/0962280207080643
Page MJ, Moher D, Brennan S, McKenzie JE. The PRISMATIC project: protocol for a research programme on novel methods to improve reporting and peer review of systematic reviews of health evidence. Syst Rev. 2023;12(1):196. Published 2023 Oct 13. doi:10.1186/s13643-023-02363-6
Higgins J, TJ CJ, Cumpston M, Li T, Page M, Welch V. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane, 2021. 2021.
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. Jun 2 2015;162(11):777-84. doi:10.7326/m14-2385
Nofal A, Nofal E. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol. 2010;24(10):1166-1170. doi:10.1111/j.1468-3083.2010.03611.x
Mohammed G, Al-Dhubaibi MS, Bahaj SS, AbdElneam AI. A review of the literature on intra-lesional immunotherapeutic intervention for the treatment of recalcitrant warts. J Pak Assoc Dermatol [Internet]. 2023Aug.7 [cited 2024Jul.22];33(3):1081-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2212
García-Oreja S, Álvaro-Afonso FJ, Tardáguila-García A, López-Moral M, García-Madrid M, Lázaro-Martínez JL. Efficacy of cryotherapy for plantar warts: A systematic review and meta-analysis. Dermatol Ther. 2022;35(6):e15480. doi:10.1111/dth.15480
Wells A, Saikaly SK, Schoch JJ. Intralesional immunotherapy for molluscum contagiosum: A review. Dermatol Ther. 2020;33(6):e14386. doi:10.1111/dth.14386
Bourke JF, Berth-Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol. 1995;132(3):433-436. doi:10.1111/j.1365-2133.1995.tb08678.x
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Amr Molla, Muhammad Tobaiqi , Hossein Elbadawy , Raed Jannadi, Heba Eltahir, Emad Albadawi, Naweed Alzaman, Mohammed Aloufi, Mekky Abouzied, Muayad Albadrani
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
